Tipranavir

This classification denotes a protease inhibitor with the molecular formula C31H33F3N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZZT404XD09, chemically known as 2-pyridinesulfonamide, n-(3-((1r)-1-((6r)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2h-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)- but generally known as tipranavir, which bears US NIH Compound Identifier 65027. European Medicines Agency schedules Tipranavir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04883MIG. The term TIPRANAVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules tipranavir in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tipranavir under HS 29350090 and SITC 51580. As of Q4 2014, TIPRANAVIR remains the US FDA Preferred Term for this commodity. Tipranavir bears US NLM identifiers UMLS ID C0663733 and NCI Concept Code C66603. SMILES: S(=O)(=O)(Nc1cc(C(C2=C(OC(CC2=O)(CCc2ccccc2)CCC)O)CC)ccc1)c1ncc(cc1)C(F)(F)F.